← All tickers

Is NUVB Worth Buying in 2026?

Nuvation Bio Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-23

Here’s whether Nuvation Bio Inc. (NUVB) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+6.21% over 10 days); RSI 61 — healthy momentum range; strong 1-year return of +152.9%; 3-month momentum positive (+46.8%). Currently 28.9% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

NUVB is in a confirmed uptrend, trading above both its 50-day ($6.08) and 200-day ($5.86) moving averages. An RSI of 61.4 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +152.9% compares to +20.5% for SPY (beat the market by 132.4%). The current 28.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $25,292 today
vs. S&P 500 (SPY) — same period beat market by 132.4%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

✓Above 200-day MA ($5.86)
✓Above 50-day MA ($6.08)
✓RSI(14) neutral zone (30–70) — currently 61.4
✓Positive return (+152.9%)
!Within 10% of period high (−28.9%)
Period Range $6.93
$2.68 $9.75
RSI (14) 61.4
0 · OversoldOverbought · 100

Key Metrics

Price$6.93
Period Return+152.9%
Period High$9.75
Period Low$2.68
Drawdown−28.9%
MA-50$6.08
MA-200$5.86
RSI (14)61.4
Avg Volume (30d)6.2M
vs. SPYbeat by 132.4%
Return Rank#71 of 999

Trade NUVB

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers